![Jane Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Grogan
Technik-/Wissenschafts-/F&E-Leiter bei
BIOGEN INC.
Vermögen: 795 368 $ am 31.05.2026
Profil
Jane Grogan is Executive Vice President & Head-Research at Biogen, Inc. since 2023.
Former roles include Chief Scientific Officer at Graphite Bio, Inc. from 2021 to 2023, Chief Scientific Officer at Arsenal Biosciences, Inc. from 2019 to 2021, and Head-Adaptive Tumor Immunity & Principal Scientist at Genentech, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Melbourne and a doctorate from the University of Leiden.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOGEN INC. 0 % | 13.02.2026 | 4.058 ( 0 % ) | 795 368 $ | 31.05.2026 |
Aktive Positionen von Jane Grogan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2023 |
Ehemalige bekannte Positionen von Jane Grogan
| Unternehmen | Position | Ende |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.09.2019 |
Ausbildung von Jane Grogan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
